ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 02, 2024 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Jacob M. Chacko, M.D., chief executive officer, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 11:15 a.m. PT.
Related news for (ORIC)
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Don’t Miss Out: MoBot’s Latest Stock Updates 05/29/25 09:00 AM
- Today’s Top Performers: MoBot’s Market Review 05/28/25 07:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 05/28/25 06:00 PM
- Today’s Top Performers: MoBot’s Market Review 05/28/25 05:00 PM